The Role of Induced Pluripotent Stem Cells in Decoding Congenital Hypopituitarism and Pituitary Development
The pituitary gland, often referred to as the "master gland" of the human endocrine system, serves as the primary regulator…
Amara Maple
Amara Maple Joy Wu Elected as 2027-2028 President of the Endocrine Society
The Endocrine Society, the world’s oldest and largest organization devoted to hormone research and the clinical practice of endocrinology, has…
The Evolution of Glucagon-Like Peptide-1 Receptor Agonists and the Transformation of Modern Metabolic Medicine
The medical landscape has been fundamentally reshaped over the last several years by the emergence of glucagon-like peptide-1 receptor agonists…
Endocrine Society Announces Chicago as Host City for ENDO 2026 Global Scientific Congress
The Endocrine Society has officially confirmed that its premier annual meeting, ENDO 2026, will be held in Chicago, Illinois, from…
Endocrine Society Leads National Advocacy Push as Congressional Impasse Over NIH Funding Threatens Medical Research Breakthroughs
The United States medical research landscape is currently facing a period of significant fiscal instability as Congress struggles to finalize…
And Just Like That, It’s 2026!
The commencement of 2026 marks a pivotal moment for the global medical community as the Endocrine Society introduces its newest…
Maternal Blood Sugar Levels Linked to Heightened Obesity Risk in Adolescents
The study challenges traditional clinical thresholds that focus primarily on full-blown gestational diabetes mellitus (GDM). Instead, it highlights a spectrum…
NYU Langone Health Appoints Marcus D. Goncalves MD PhD as Director of the Holman Division of Endocrinology Diabetes and Metabolism
NYU Langone Health has officially announced the appointment of Marcus D. Goncalves, MD, PhD, as the new director of the…
Inflammation-associated Lipidomic Signatures Prior to Carotid Artery Atherosclerosis in People Living With HIV.
This landmark study, recently published in The Journal of Clinical Endocrinology & Metabolism, reveals a breakthrough in cardiovascular risk assessment…
FDA Approval and Launch of 25 mg Oral Semaglutide Marks a New Era in Chronic Weight Management and Cardiovascular Risk Reduction
The landscape of metabolic medicine underwent a significant transformation in early January 2026 as the 25 mg oral formulation of…
